Aptamers are high affinity molecules that are derived from RNA or DNA. These are normally generated using a synthetic process called 'Systematic evolution of ligands by exponential enrichment? (SELEX).
The global aptamers market is poised for rapid growth between 2018 and 2025. Factors such as strong trend of R&D investments in biotechnology and pharmaceutical industries, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies are driving the growth of the aptamers market.
The classification of Aptamers includes DNA-Based Aptamers, RNA-Based Aptamers, and the proportion of DNA-Based Aptamers in 2017 is about 73%

According to this study, over the next five years the Aptamers market will register a 12.3% CAGR in terms of revenue, the global market size will reach US$ 78 million by 2024, from US$ 44 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Aptamers business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Aptamers market by product type, application, key manufacturers and key regions and countries.

This study considers the Aptamers value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
DNA-Based Aptamers
RNA-Based Aptamers
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Research and Development
Drug Discovery

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
TriLink BioTechnologies
AptaBharat
SomaLogic
AM Biotechnologies
Aptamer Sciences
Base Pair Biotechnologies
Aptamer Group
Aptagen
Aptus Biotech
NeoVentures Biotechnology
Ray Biotech
Vivonics

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Aptamers consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Aptamers market by identifying its various subsegments.
Focuses on the key global Aptamers manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Aptamers with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Aptamers submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.